Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification and Semi -Quantification of ER/PR Proteins Expression Status in Formalin Fixed, Paraffin-embedded Normal and Neoplastic Tissue

NCT02654431 is registered in ClinicalTrials.gov with Applied Spectral Imaging Ltd. as lead sponsor.

NCT NCT02654431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02654431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification and Semi -Quantification of ER/PR Proteins Expression Status in Formalin Fixed, Paraffin-embedded Normal and Neoplastic Tissue
Lead sponsor
Applied Spectral Imaging Ltd.
Phase
Observational
Overall status
Completed
Start date
May 31, 2013
Completion date
December 31, 2014
Enrollment
350 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer